• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB" [Biomed. Pharmacother. 108 (2018) 316-324].

作者信息

Yuchen Sun, Jizhao Wang, Shupei Pan, Tian Yang, Xuanzi Sun, Ya Wang, Xiaobo Shi, Xu Zhao, Jing Guo, Xiaozhi Zhang

机构信息

Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

The Second Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

出版信息

Biomed Pharmacother. 2019 Mar;111:1507. doi: 10.1016/j.biopha.2018.12.032. Epub 2018 Dec 30.

DOI:10.1016/j.biopha.2018.12.032
PMID:30600121
Abstract
摘要

相似文献

1
Corrigendum to "LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB" [Biomed. Pharmacother. 108 (2018) 316-324].《“LINC00657 通过靶向 miR-615-3p 和 JunB 在食管鳞状细胞癌中发挥致癌作用”的勘误》[《生物医学与药物治疗》108 (2018) 316 - 324]
Biomed Pharmacother. 2019 Mar;111:1507. doi: 10.1016/j.biopha.2018.12.032. Epub 2018 Dec 30.
2
Corrigendum to "Folate inhibits miR-27a-3p expression during cervical carcinoma progression and oncogenic activity in human cervical cancer cells" [Biomed. Pharmacother. 122 (2020) 109654].《“叶酸在宫颈癌进展过程中抑制miR-27a-3p表达及在人宫颈癌细胞中的致癌活性”的勘误》[《生物医学与药物治疗》122卷（2020年）109654页]
Biomed Pharmacother. 2020 May;125:109981. doi: 10.1016/j.biopha.2020.109981. Epub 2020 Feb 15.
3
Corrigendum to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" [Biomed. Pharmacother. 110 (2019) 656-666].《“MiR-23a-3p通过靶向PNRC2在肾细胞癌中作为癌基因和潜在预后生物标志物”的勘误》[《生物医学与药物治疗》110 (2019) 656 - 666]
Biomed Pharmacother. 2019 Apr;112:108755. doi: 10.1016/j.biopha.2019.108755. Epub 2019 Mar 11.
4
miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.微小RNA-483-3p通过靶向肿瘤抑制因子EI24在食管鳞状细胞癌中发挥致癌作用。
Cell Biol Int. 2016 Apr;40(4):448-55. doi: 10.1002/cbin.10585. Epub 2016 Feb 4.
5
Corrigendum to "MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma" [Biomed. Pharmacother. 98 (2018) 680-686].《“MicroRNA-30c通过靶向SNAI1在食管鳞状细胞癌中发挥肿瘤抑制作用”的勘误》[《生物医学与药物治疗》98 (2018) 680 - 686]
Biomed Pharmacother. 2024 Oct;179:117376. doi: 10.1016/j.biopha.2024.117376. Epub 2024 Sep 2.
6
Corrigendum to "MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway" [Biomed. Pharmacother. 118 (2019) 109111].《“MiR-25-3p通过调控PTEN/Akt通路促进视网膜母细胞瘤的恶性表型”的勘误》[《生物医学与药物治疗》118卷（2019年）第109111页]
Biomed Pharmacother. 2020 Nov;131:110842. doi: 10.1016/j.biopha.2020.110842. Epub 2020 Oct 19.
7
MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.miR-455-3p 通过靶向 FAM83F 作为一个预后标志物抑制食管鳞癌细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3200-3206.
8
MiR-433-3p Inhibits Proliferation and Invasion of Esophageal Squamous Cell Carcinoma by Targeting GRB2.MiR-433-3p通过靶向GRB2抑制食管鳞状细胞癌的增殖和侵袭。
Cell Physiol Biochem. 2018;46(5):2187-2196. doi: 10.1159/000489548. Epub 2018 Apr 28.
9
Corrigendum to "Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis" [Biomed. Pharmacother. 125 (2020) 110001].《右美托咪定通过miR-208b-3p/Med13/ Wnt信号通路轴保护H9C2细胞免受缺氧/复氧损伤》的勘误 [《生物医学与药物治疗》125卷（2020年）110001]
Biomed Pharmacother. 2020 Oct;130:110841. doi: 10.1016/j.biopha.2020.110841. Epub 2020 Oct 5.
10
Retraction notice to "MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC)" [Biomed. Pharmacother. 76 (2015) 82-93].撤回声明：“MiR-1290通过靶向食管鳞状细胞癌（ESCC）中的核因子I/X（NFIX）促进癌症进展”[《生物医学与药物治疗》76（2015）82-93] 。
Biomed Pharmacother. 2024 Feb;171:116189. doi: 10.1016/j.biopha.2024.116189. Epub 2024 Jan 30.